Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
放射治疗联合紫杉醇加帕唑帕尼或安慰剂治疗间变性甲状腺癌（NRG/RTOG 0912）：一项随机、双盲、安慰剂对照、多中心 II 期试验
期刊:Lancet Oncology
影响因子:35.9
doi:10.1016/S1470-2045(22)00763-X
Sherman, Eric J; Harris, Jonathan; Bible, Keith C; Xia, Ping; Ghossein, Ronald A; Chung, Christine H; Riaz, Nadeem; Gunn, G Brandon; Foote, Robert L; Yom, Sue S; Wong, Stuart J; Koyfman, Shlomo A; Dzeda, Michael F; Clump, David A; Khan, Saad A; Shah, Manisha H; Redmond, Kevin; Torres-Saavedra, Pedro A; Le, Quynh-Thu; Lee, Nancy Y
